Publication dates

Cell Therapy Industry, July 2014 Market Reports from Top Publishers

You might be interested in: medical equipment, cancer, therapeutics, more »


 
1-10 of about 200 reports for Cell Therapy

Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

Sunzen Biotech Bhd

Sunzen Biotech Bhd

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Sunzen Biotech Bhd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

Zhongyuan Union Stem Cell Bio-Engineering Corp

Zhongyuan Union Stem Cell Bio-Engineering Corp

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Zhongyuan Union Stem Cell Bio-Engineering Corp compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

Chiome Bioscience Inc

Chiome Bioscience Inc

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Chiome Bioscience Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

Carna Biosciences Inc

Carna Biosciences Inc

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Carna Biosciences Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

Shanghai Jiaoda Onlly Co., Ltd.

Shanghai Jiaoda Onlly Co., Ltd.

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Shanghai Jiaoda Onlly Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

There are today 120 companies plus partners developing 107 gene therapy drugs in 276 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 332 companies plus partners developing 441 Androgen Receptor drugs in 1457 developmental projects in cancer. ...

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-recepto ...

EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The EGFR1 signaling pathway activates the Ras/Raf/MAPK signaling modules. There are today 371 companies plus partners developing 642 EGFR1 pathway targeting drugs in 2397 developmental projects in cancer. ...

About 500 reports for Cell Therapy

Download Unlimited Documents from Trusted Public Sources

Cell Therapy Markets in the US

  • Invivo Therapeutics Holdings Corp. Rating: Buy
  • July 2012
    38 pages
  • Cell Therapy  

    Stem Cell  

  • United States  

View report >

3 Companies for Cell Therapy

Read our Company Profiles

Bioheart Inc.

United States

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.